These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8022396)

  • 1. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jul; 43(28):505-9. PubMed ID: 8022396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the Centers for Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    JAMA; 1994 Aug; 272(6):424-5. PubMed ID: 8040966
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study.
    Bresee JS; Mast EE; Coleman PJ; Baron MJ; Schonberger LB; Alter MJ; Jonas MM; Yu MY; Renzi PM; Schneider LC
    JAMA; 1996 Nov; 276(19):1563-7. PubMed ID: 8918853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An outbreak of acute hepatitis C among recipients of intravenous immunoglobulin.
    Flora K; Schiele M; Benner K; Montanaro A; Johnston W; Whitham R; Press R
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):160-2. PubMed ID: 8595535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006.
    Williams IT; Bell BP; Kuhnert W; Alter MJ
    Arch Intern Med; 2011 Feb; 171(3):242-8. PubMed ID: 21325115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal insufficiency and failure associated with immune globulin intravenous therapy--United States, 1985-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jun; 48(24):518-21. PubMed ID: 10401909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of hepatitis C virus in allografted patients: use of viral genotyping as an epidemiological marker.
    Gangneux JP; Traineau R; Tuveri R; Ravera N; Bureau C; Gluckman E; Benbunan M; Loiseau P
    Bone Marrow Transplant; 1996 Dec; 18(6):1131-3. PubMed ID: 8971383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.
    Healey CJ; Sabharwal NK; Daub J; Davidson F; Yap PL; Fleming KA; Chapman RW; Simmonds P; Chapel H
    Gastroenterology; 1996 Apr; 110(4):1120-6. PubMed ID: 8613001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
    Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G
    Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission.
    Berger A; Doerr HW; Scharrer I; Weber B
    J Med Virol; 1997 Sep; 53(1):25-30. PubMed ID: 9298728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users--new York, November 2004-April 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 May; 57(19):517-21. PubMed ID: 18480744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis C following administration of intravenous immunoglobulins].
    Cabrera Chaves T; Simón Marco MA; Gomollón García F; Botella Esteban MT; Uribarrena Echebarría R
    Gastroenterol Hepatol; 1996; 19(6):305-8. PubMed ID: 8754418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.
    Wang CC; Krantz E; Klarquist J; Krows M; McBride L; Scott EP; Shaw-Stiffel T; Weston SJ; Thiede H; Wald A; Rosen HR
    J Infect Dis; 2007 Nov; 196(10):1474-82. PubMed ID: 18008226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low rate of HCV transmission from women infected with contaminated anti-D immunoglobulin to their family contacts.
    Sachithanandan S; Fielding JF
    Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):47-50. PubMed ID: 9265578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outbreak of hepatitis C virus infection in an outpatient clinic.
    Ishikawa T; Fukushima Y; Shiobara Y; Kishimoto T; Tanno S; Shoji I; Suzuki T; Matsui T; Shimada Y; Ohyama T; Nagai R; Miyamura T
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1087-93. PubMed ID: 15955219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region.
    Defossez G; Verneau A; Ingrand I; Silvain C; Ingrand P; Beauchant M;
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):367-72. PubMed ID: 18403936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta.
    Meky FA; Stoszek SK; Abdel-Hamid M; Selim S; Abdel-Wahab A; Mikhail N; El-Kafrawy S; El-Daly M; Abdel-Aziz F; Sharaf S; Mohamed MK; Engle RE; Emerson SU; Purcell RH; Fix AD; Strickland GT
    Clin Infect Dis; 2006 Mar; 42(5):628-33. PubMed ID: 16447107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
    Shores NJ; Maida I; Soriano V; Núnez M
    J Hepatol; 2008 Sep; 49(3):323-8. PubMed ID: 18486266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.